Template:Monoamine releasing agents: Difference between revisions
From WikiMD's Wellness Encyclopedia
CSV import |
en>Irruptive Creditor m Merger of propylhexedrine with evopropylhexedrine |
||
| Line 72: | Line 72: | ||
* [[4-Hydroxyamphetamine]] | * [[4-Hydroxyamphetamine]] | ||
* [[Iofetamine (123I)]] | * [[Iofetamine (123I)]] | ||
* [[Lisdexamfetamine]] | |||
* [[Lophophine]] | * [[Lophophine]] | ||
* [[Mefenorex]] | * [[Mefenorex]] | ||
| Line 140: | Line 141: | ||
* [[Phenylbiguanide]] | * [[Phenylbiguanide]] | ||
* [[Propylhexedrine]] | * [[Propylhexedrine]] | ||
}} | }} | ||
| Line 280: | Line 280: | ||
* [[Octodrine]] | * [[Octodrine]] | ||
* [[Phthalimidopropiophenone]] | * [[Phthalimidopropiophenone]] | ||
* [[Propylhexedrine]] | * [[Propylhexedrine]] | ||
* [[Tuaminoheptane]] | * [[Tuaminoheptane]] | ||
| Line 408: | Line 408: | ||
| group4 = Others | | group4 = Others | ||
| list4 = | | list4 = | ||
* ''DAT modulators:'' ''Agonist-like:'' [[SoRI-9804]] | * ''DAT modulators:'' ''Agonist-like:'' [[SoRI-9804]] | ||
| Line 427: | Line 426: | ||
[[Category:Drug templates by receptor, channel, or pump]] | [[Category:Drug templates by receptor, channel, or pump]] | ||
</noinclude> | </noinclude> | ||
Revision as of 21:24, 7 October 2024
| Monoamine releasing agents | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
